<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02085772</url>
  </required_header>
  <id_info>
    <org_study_id>WENDREMAIRE APJ 2013</org_study_id>
    <nct_id>NCT02085772</nct_id>
  </id_info>
  <brief_title>Leukocytes - ObeSity - Spontaneous Labour</brief_title>
  <acronym>LOST</acronym>
  <official_title>Is Impaired Activation and Migration of Circulating Leukocytes Associated With Overdue Birth in Obese Women?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This is a single-centre observational, prospective study carried out at the maternity unit of&#xD;
      Dijon CHU. It will include pregnant women with a pre-conception BMI ≥ 30 kg/m² and will&#xD;
      evaluate in these patients, the activation and migration capacities of circulating leukocytes&#xD;
      and their association with the onset of spontaneous labour.&#xD;
&#xD;
      Patients who meet the inclusion criteria will be informed about the study during their&#xD;
      consultation at the 7th or 8th month, and their gynecologist will invite them to take part.&#xD;
      If the answer is positive, the patients will be seen again at a specific consultation for the&#xD;
      study between the 37th and 38the Weeks of amenorrhea at the maternity unit of Dijon CHU.&#xD;
      During this consultation, the gynecologist will conduct a medical examination, while the&#xD;
      Plurithematic clinical investigation center nurse will take a blood sample (3 x 6ml tubes and&#xD;
      1 x 7ml tube).&#xD;
&#xD;
      If labour has not started by 41 Weeks of amenorrhea, the patients will be seen at another&#xD;
      consultation (consultation programmed in the usual follow-up of pregnancy) and a second blood&#xD;
      sample (1 x 6ml tube and 1 x 7ml) will be taken.&#xD;
&#xD;
      The patients will be followed until childbirth and will be split into two groups according to&#xD;
      whether or not they gave birth after the onset of spontaneous labour.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2014</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the initiation of spontaneous labour</measure>
    <time_frame>Women will be followed until the release of motherhood after giving birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of a vaginal delivery</measure>
    <time_frame>Women will be followed until the release of motherhood after giving birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of prolonged pregnancy</measure>
    <time_frame>Women will be followed until the release of motherhood after giving birth</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of a term exceeding</measure>
    <time_frame>Women will be followed until the release of motherhood after giving birth</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pre-conceptional Obesity</condition>
  <arm_group>
    <arm_group_label>Patients with pre-conceptional obesity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples at 37-38 Weeks of amenorrhea</intervention_name>
    <arm_group_label>Patients with pre-conceptional obesity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood samples at 41 Weeks of amenorrhea if prolonged pregnancy</intervention_name>
    <arm_group_label>Patients with pre-conceptional obesity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient has given its written consent&#xD;
&#xD;
          -  Please affiliated to a social security scheme&#xD;
&#xD;
          -  Body Mass Index Preconception ≥ 30 kg / m²&#xD;
&#xD;
          -  Age&gt; 18 years&#xD;
&#xD;
          -  Unique Pregnancy&#xD;
&#xD;
          -  Having a plot of Normal Fetal heart rate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pathology changing the mode of delivery or induction of labor (pre-eclampsia, chronic&#xD;
             hypertension or gestational, diabetes under unbalanced diet, ...)&#xD;
&#xD;
          -  Scheduled Caesarean&#xD;
&#xD;
          -  Infectious Disease suspected or proven, including HIV infection, hepatitis C,&#xD;
             hepatitis B&#xD;
&#xD;
          -  Pathology inflammatory or autoimmune&#xD;
&#xD;
          -  Anti-inflammatory or immunosuppressive therapy&#xD;
&#xD;
          -  Patient under guardianship&#xD;
&#xD;
          -  Patient in safeguarding justice&#xD;
&#xD;
             • SECONDARY EXCLUSION CRITERIA:&#xD;
&#xD;
          -  Caesarean section before labor&#xD;
&#xD;
          -  Delivery before 37 Weeks of amenorrhea&#xD;
&#xD;
          -  Anti-inflammatory or immunosuppressive therapy during study participation&#xD;
&#xD;
          -  Fetal Heart Rate abnormal during study participation&#xD;
&#xD;
          -  Premature rupture of fetal membranes without formal labor spontaneously within 48&#xD;
             hours&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maeva WENDREMAIRE</last_name>
    <phone>3 80 29 52 05</phone>
    <phone_ext>+33</phone_ext>
    <email>maeva.wendremaire@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maeva WENDREMAIRE</last_name>
      <phone>3 80 29 52 05</phone>
      <phone_ext>+33</phone_ext>
      <email>maeva.wendremaire@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

